Autonomix Medical, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AMIX Nasdaq 3840 autonomix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Autonomix Medical, Inc.

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - Jan 9th, 2026 6:45 am
BC-Most Active Stocks - Dec 30th, 2025 8:30 am
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - Dec 30th, 2025 6:30 am
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - Dec 23rd, 2025 6:45 am
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - Dec 18th, 2025 6:30 am
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth - Nov 26th, 2025 6:45 am
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules - Nov 18th, 2025 6:30 am
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study - Nov 17th, 2025 6:00 am
Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference - Oct 24th, 2025 7:00 am
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit - Oct 16th, 2025 7:15 am
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - Oct 9th, 2025 6:45 am
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - Oct 2nd, 2025 6:45 am
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System - Sep 29th, 2025 7:15 am
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress - Sep 9th, 2025 7:00 am
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment - Sep 4th, 2025 7:00 am
Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study - Sep 3rd, 2025 6:30 am
Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference - Sep 2nd, 2025 6:30 am
Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology - Aug 20th, 2025 6:30 am
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc. - Aug 18th, 2025 7:15 am
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - Aug 15th, 2025 8:00 am